WORLDREMIT
4.2.2021 02:56:08 CET | Business Wire | Press release
WorldRemit, a leading digital cross-border payments business has announced the winners of its recent Grainsmart store franchise promotion to help customers give their beneficiaries the opportunity to start a business in the Philippines. Customers qualified for the promotion by sending money to the Philippines and nominating a beneficiary of their choice. The winners include frontline healthcare workers and teachers from a number of countries including the United Kingdom, Norway, Australia, Canada, New Zealand, Sweden and the United States. Beneficiaries will now be opening Grainsmart stores across the Philippines in places which include Cebu, Davao, San Carlos and Tagum City.
“We’re so pleased to give recipients this great opportunity to start a business that will help them to support their families and become more financially stable. The franchisees have the option to expand these businesses and potentially create job opportunities for members of the wider community. This underlines our commitment to helping Overseas Filipino Workers to support those dearest to them back home,” said Earl Melivo, Country Director for the Philippines at WorldRemit.
Benjamin Batac, CEO at Grainsmart added, “It’s an honour to partner with a company like WorldRemit that shares our values. With many of the franchise contracts already signed, this promotion will create sustainable jobs and also give much-needed support to Filipino farmers, many of whom are facing challenges due to the pandemic and recent natural disasters”.
Winner Emilie Ann Estavas who works as a healthcare assistant in a care home in Oxfordshire said, “I’m very happy and excited with the prize and so grateful to WorldRemit and Grainsmart. It is really a surprise. The Pangkabuhayan package will help my family back in the Philippines to start a business which is a huge blessing and a big help. It is a great opportunity and I’m planning to expand the business while we are here still working abroad. I am hoping and praying that God will bless the business and make it prosper so that in the near future it will help us to retire early, go home and continue running the business with my family. Fingers crossed!”.
Winner and frontline worker Melissa Zibas has chosen her cousin Adan who lives in San Carlos City, Pangasinan as her beneficiary. She said, “Adan is a former seafarer and is pretty adventurous like me so I know he’ll make a huge success of the Grainsmart business. We’re a very close family so I hope we can grow the business and include other members of our family. The covid-19 pandemic has really tested everyone's lives so it's great to start a business that will be needed by people as rice is our staple food”.
Rosa Mae who lives in Norway and is studying to become a youth worker, chose her sister Rhea as her beneficiary. Rhea who lives and works in Tagum City as a doctor’s secretary said, “I’m so grateful to my big sister for giving me this opportunity. I miss her so much now that she lives over 10,000 miles away in Oslo. Sending transfers through WorldRemit is her way of supporting and staying connected to us and now it has given me the chance to start my own business. We grew up in Davao de Oro and our parents still live there so I’m looking forward to running the Grainsmart franchise with them”.
Each Grainsmart franchise business package includes:
- 60 sacks (25 kg each) of rice
- A tablet that’s fully set up for a bills payment center account
- Business signage, marketing collateral, and other business paraphernalia
- An online training and mentorship program – to provide guidance for setting up the business for success
As well as the COVID-19 pandemic, Filipinos have also had to deal with the devastation caused by Super Typhoon Goni and Typhoon Vamco, which have displaced thousands and destroyed livelihoods.
Take advantage of competitive exchange rates for the Philippine peso by visiting www.worldremit.com or downloading the app.
Winners were announced on the WorldRemit Facebook page (https://www.facebook.com/WorldRemit/ ).
For more details visit www.worldremit.com/pangkabuhayan .
WorldRemit
WorldRemit is a leading digital cross-border payments business. We disrupted an industry previously dominated by offline legacy players by taking international money transfers online - making them safer, faster and lower-cost. We currently send from more than 50 countries to 130+ receive countries, operate in 6,500 money transfer corridors worldwide and employ over 1,100 people worldwide.
On the sending side WorldRemit is 100% digital (cashless), increasing convenience and enhancing security. For those receiving money, the company offers a wide range of options including bank deposit, cash collection, mobile airtime top-up and mobile money.
Backed by Accel, TCV and Leapfrog – WorldRemit’s headquarters are in London, United Kingdom with regional offices in the United States, Canada, Australia, New Zealand, Hong Kong, Singapore, Malaysia, the Philippines, South Africa, Somaliland, Uganda, Kenya, Rwanda, Tanzania, Zimbabwe and Belgium.
For more information visit www.worldremit.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210203006021/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom